← Back to Clinical Trials
Recruiting Phase 2 NCT07022470
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Trial Parameters
Condition Cervical Cancers
Sponsor Stanford University
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 41
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-06-03
Completion 2028-06
Interventions
3-Fraction HDR Brachytherapy4-Fraction HDR Brachytherapy
Brief Summary
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Eligibility Criteria
Inclusion Criteria: * Histologically documented malignancy of the cervix and planned to receive brachytherapy as part of definitive treatment. * ECOG performance status of 0-2 * Age ≥ 18 years old. * Ability to understand and the willingness to provide written informed consent. Exclusion Criteria: * Contraindication to receiving radiotherapy as determined by treating radiation oncologist. * Contraindication to receiving MRI. * Prior radiation to the pelvis \> 3 months ago * Age \< 18 years old. * Pregnant or breast-feeding
Related Trials
NCT06815939
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
View Trial →
NCT06919627
Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: W
View Trial →
NCT07022470
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
View Trial →